Search for: "MERCK " Results 61 - 80 of 3,321
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jun 2023, 1:38 am by Kurt R. Karst
Both Merck (maker of Januvia, Janumet, and Keytruda) and BMS (maker of Eliquis and Opdivo) argue that the IRA is unconstitutional under the First Amendment because it compels speech and under the Fifth Amendment because it represents an uncompensated taking. [read post]
15 Jun 2023, 7:00 am by Laura Dolbow
Like the 340B plaintiffs, Merck argues that the Medicare price negotiation program will coerce Merck into selling drugs at discounted prices. [read post]
9 Jun 2023, 1:45 pm by KATIE ADAMS - MEDCITY NEWS
The post Why One Healthcare Lawyer Thinks Merck’s Drug Pricing Lawsuit Defense ‘Makes No Sense’ appeared first on Above the Law. [read post]
9 Jun 2023, 6:24 am by Chris Castle
Merck addressed this very point: One of the things we have a real issue with on behalf of the songwriting community is data. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
28 May 2023, 12:03 pm by Chris Castle
The Five Year Plan Merck Mercuriadis makes the good point that there is no time like the present to evolve: “In the United States, we have a position of stability for the next five years – at the highest rates paid to songwriters to date – in the evolution of the streaming economy. [read post]
The malware, which was delivered to Merck’s computers through accounting software developed by a Ukrainian company, allegedly spread to 40,000 Merck computers, caused more than $1.4 billion in losses and hurt Merck’s revenues. [read post]
” In so doing, the court summarized the blocking patents doctrine as follows: In Merck and Galderma, we held that where market entry by others was precluded due to blocking patents, the inference of non-obviousness of the asserted claims from evidence of commercial success may be weak. [read post]
9 May 2023, 11:03 am by Stewart Baker
  Jim explains the state appellate court decision ruling that the NotPetya attack on Merck was not an act of war and thus not excluded from its insurance coverage. [read post]
8 May 2023, 6:54 pm by Stewart Baker
Jim explains the state appellate court decision ruling that the NotPetya attack on Merck was not an act of war and thus not excluded from its insurance coverage. [read post]
4 May 2023, 2:31 pm by Mark D. Rasch
The Merck court faulted the exclusionary language as being ultimately too broad and not tailored to spe [read post]
2 May 2023, 7:07 am by Legal Profession Prof
The New Jersey Appellate Court affirmed the grant of insurance coverage for a cyberattack on Merck On leave to appeal, we consider whether plaintiff Merck & Co., Inc. [read post]
2 May 2023, 7:00 am by Bradley Merrill Thompson
  As you can see from the heat chart, Merck likes to submit follow-on FOIA requests, and when you look at the chart about company success rates, Merck is very successful in it. [read post]